These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 16321763
1. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. Tanaka M, Ino Y, Nakagawa K, Tago M, Todo T. Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763 [Abstract] [Full Text] [Related]
2. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M. Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527 [Abstract] [Full Text] [Related]
3. Radiotherapy in supratentorial gliomas. A study of 821 cases. Heesters M, Molenaar W, Go GK. Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126 [Abstract] [Full Text] [Related]
5. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy]. Wu SX, Deng ML, Li QQ, Zhao C, Lu TX, Li FY, Cui NJ. Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680 [Abstract] [Full Text] [Related]
10. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma]. Zhou WN, Chen ZP, You C, Mu YG, Sai K, Zhang JY, Zhang XH, Cheng JJ, Xu HC. Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679 [Abstract] [Full Text] [Related]
11. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA. Int J Radiat Oncol Biol Phys; 2006 Mar 01; 64(3):892-7. PubMed ID: 16458777 [Abstract] [Full Text] [Related]
12. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society. J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063 [Abstract] [Full Text] [Related]